Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
(Bizalimogene ralaplasmid + mavilimogene ralaplasmid) by Inovio Pharmaceuticals for Anal Dysplasia: Likelihood of Approval
(Bizalimogene ralaplasmid + mavilimogene ralaplasmid) is under clinical development by Inovio Pharmaceuticals and currently in Phase II for Anal Dysplasia....